Seward simplifies cell preparation
Enhances applications for Strainer bags to include sterile processing of tissue samples
Gamma irradiated sterile and available in a range of sizes, the Strainer bags are compatible with all laboratory paddle blenders, including Seward’s Stomacher 80 Biomaster series. Because they are fully containable and easily used in a sterile environment, the Strainer bags can be used for new applications in cell culture.
The 0.5mm pore size of the integrated strainer element within the Seward Strainer bag generates a uniformly homogenous cell suspension, says the Worthing-based company. This allows the cells’ passage through the pores of the central straining matrix and prevents contamination with undigested extracellular material, which can block pipettes. Produced to provide a sterile, secure environment for the preparation of single cell suspensions, the Strainer bag is suitable for the individual processing of a large number of samples.
“The new life-science applications of our robust Strainer bag technology represent the continuing, customer oriented, development to which Seward is committed,” said Stuart Ray, technical director at Seward Ltd.
“Cell scientists can simplify their primary culture preparations by straining the processed tissues to ensure trouble-free pipetting, whilst also increasing the viability of the cells produced as the end product.”
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model